Genome wide underpinning of antagonistic and plant beneficial attributes of Bacillus sp. SBA12.
Comparative genomics
Genes
Genome
Microorganism
Next generation sequencing
Journal
Genomics
ISSN: 1089-8646
Titre abrégé: Genomics
Pays: United States
ID NLM: 8800135
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
11
12
2019
revised:
28
02
2020
accepted:
30
03
2020
pubmed:
5
4
2020
medline:
10
4
2021
entrez:
5
4
2020
Statut:
ppublish
Résumé
The plant beneficial microorganisms in rhizosphere are promising candidates to counter plant biotic and abiotic stresses. In the present study, Bacillus sp. SBA12 antagonistic to plant pathogenic fungi such as Phytophthora infestans and Sclerotinia sclerotiorum was explored. The complete genome of SBA12 comprises 5,297,566 bp size with GC content 49% and a total of 5698 genes. The genomic organization revealed presence of several biosynthetic clusters for antibiotics, siderophore and various other bioactive compounds such as lanthipeptide, LAP, bacteriocin, siderophore, NRP and terpenes. The gene cluster for fengycin known for its role as elicitors in inducing plant immunity is also reported. Besides this, lytic enzymes chitinases, β-glucanases and proteases involved in pathogen suppression, acid and alkaline phosphatases, deaminases responsible for the phosphate solubilization and release of ammonia are also reported. The genomic organization of SBA12 revealed several hallmarks for plant growth promotion and pathogen suppression activities.
Identifiants
pubmed: 32247006
pii: S0888-7543(19)30992-9
doi: 10.1016/j.ygeno.2020.03.029
pii:
doi:
Substances chimiques
6-Phytase
EC 3.1.3.26
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2894-2902Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.